I'll try....
Dear Miracle,
I will attempt to answer your questions.
1. Phase 1 trials result from pre-clinical activity with the drug usually with animals. A phase 1 trial is a trial that ties to accomplish 2 basic things, (if anyone wants to shout-in, please do), to see if there is a drug response in humans and not just animals and even more importantly, to find the most tolerable dose without dose-limiting side effects. If there is activity in phase 1 and not too much toxicity, it goes to phase 2 and then finally phase 3. Time to approval? 10 years if everything goes OK
2. depends on where the mets are and the status of your disease, ie. active, stable or NED
3. Avastin was first approved for CRC and is now being tested in other cancers. You gotta start somewhere and Genentech decided to go with CRC probably because of the molecular markers and the size of the CRC market.
I hope this was helpful and I'm sure others will add to this.
Al
__________________
Primary care-giver to and advocate for Linda, who passed away April 27, 2006.
|